Search
for
Sort by
Research 181–210 of 1000+
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- The dose‐response of percutaneous oestradiol implants on the skeletons of postmenopausal women
- Polycystic Ovary Syndrome
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Diagnosis of hyperandrogenism: Biochemical criteria
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- 9 Diagnosis and therapy of hyperandrogenism
- Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland
- The Immun System Response İn Covıd-19 Infectıon İn Polycystıc Ovary Syndrome
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Botulinum Toxin Off-Label Use in Dermatology: A Review
- Scalp Itch: A Systematic Review
- Frontal Alopecia after Repeated Botulinum Toxin Type A Injections for Forehead Wrinkles: An Underestimated Entity?
- Nonclassic adrenal hyperplasia
- Serum Vitamin D levels in males with premature androgenetic alopecia: a prospective case-control study
- Anti-androgenic and Hair Growth Promoting Activities of Lygodii Spora (Spore of Lygodium japonicum) I. Active Constituents Inhibiting Testosterone 5.ALPHA.-Reductase.
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Dermatologic manifestations of endocrine disorders
- Androgen excess: a hallmark of polycystic ovary syndrome
- Androgen effects on the skin
- How should postmenopausal androgen excess be evaluated?
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Anabolic-androgenic steroids and cardiovascular risk